Introduction {#Sec1}
============

Sepsis is characterized by a complex systemic inflammatory response to infection. While an overwhelming pro-inflammatory response is held responsible for early deaths, subsequent anti-inflammatory cytokine production may lead to immunosuppression and secondary infections. This has been suggested as a cause of intermediate-term deaths\[[@CR1]\].

Objectives {#Sec2}
==========

To study the relation between a persistent anti-inflammatory response and day 4-14 mortality in patients with severe sepsis and septic shock who have survived beyond the initial pro-inflammatory phase.

Methods {#Sec3}
=======

We included consecutive patients admitted with severe sepsis or septic shock to the Intensive Care Units (ICU) of 2 tertiary care centres in The Netherlands between January 2011 and July 2013 with a length of stay of at least 4 days. We excluded patients with prior immune deficiency. The anti-inflammatory response was assessed through interleukin (IL)-10 plasma concentrations on admission, day 2, and day 4 using BD™ CBA Flex Set system immunoassays. We categorized patients into 3 groups (low, moderate, high) based on day 4 IL-10 percentiles ( \< 25^th^, 25-75^th^, \>75^th^) and change from day 2 values. We measured IL-6 as marker of pro-inflammation. We used multivariable logistic regression analysis to study the relation with day 4-14 mortality and control for confounding.

Results {#Sec4}
=======

We enrolled 485 patients; of these, we excluded 116 cases because of known immune deficiency and 19 cases because of missing plasma samples, leaving 350 subjects for analysis. A total of 148 (42%) patients were categorized as having a low anti-inflammatory response, 122 (35%) as moderate, and 80 (23%) as high. The groups were similar with respect to age, gender, and ICU length of stay (LOS), but patients with high anti-inflammatory response had higher Apache IV scores and were diagnosed with more abdominal and less pulmonary infections. Mortality between day 4 and 14 was 14%, 9% and 36% for patients with low, moderate, and high IL-10 levels, respectively (p= \< 0.01). After adjustment for age, comorbidities, sequential organ failure assessment score, site of infection and IL-6 response in the first 4 days of ICU admission, a persistent high anti-inflammatory response on day 4 remained independently associated with increased mortality (crude odds ratio high vs. low 3.4; adjusted 2.8, 95% CI 1.4-5.7).

Conclusions {#Sec5}
===========

High anti-inflammatory response after 4 days is an independent risk factor for intermediate-term mortality in critically ill patients with sepsis.
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This study was performed within the Molecular diagnosis And Risk stratification of Sepsis (MARS) project (grant-04l-201).Table 1Patient characteristics.Low IL-10 level (n = 148)Moderate IL-10 level (n = 122)High IL-10 level (n = 80)p-valueAge, median (IQR)65 (56-73)62 (53-73)66 (59-73)0.22Gender (male), n (%)94 (64%)75 (62%)45 (56%)0.55Charlson Comorbidity Index, median (IQR)4 (0-10)4 (0-9)5 (0-11)0.75Apache IV score, median (IQR)82 (67-99)83 (69-102)87 (71-113)0.06ICU length of stay, median (IQR)10 (6-17)10 (7-19)10 (7-19)0.38Total SOFA score day 3, median (IQR)8 (6-10)9 (7-11)10 (8-13)\< 0.01IL-6 day 4 (pg/ml)\*, median (IQR)3 (2.3-4)3.9 (3.0-4.7)4.7 (4-5.5)\< 0.01Day-14 mortality, n (%)21 (14%)11 (9%)29 (36%)\< 0.01IQR=Interquartile range. SOFA = Sequential Organ Failure Assessment. Difference between groups (low, moderate, high) was tested by one-way ANOVA or Kruskal-Wallis test for continuous variables as appropriate. Differences between groups for categorical variables was tested for using a Chi-square test. \* Log transformed
